DE602004017504D1 - Impfstoffzusammensetzung im gemisch mit einem alkylphosphatidylcholin - Google Patents

Impfstoffzusammensetzung im gemisch mit einem alkylphosphatidylcholin

Info

Publication number
DE602004017504D1
DE602004017504D1 DE200460017504 DE602004017504T DE602004017504D1 DE 602004017504 D1 DE602004017504 D1 DE 602004017504D1 DE 200460017504 DE200460017504 DE 200460017504 DE 602004017504 T DE602004017504 T DE 602004017504T DE 602004017504 D1 DE602004017504 D1 DE 602004017504D1
Authority
DE
Germany
Prior art keywords
mixture
vaccine composition
alkyl
pharmaceutical composition
additionally contains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE200460017504
Other languages
English (en)
Inventor
Jean Haensler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Inc
Original Assignee
Sanofi Pasteur Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Inc filed Critical Sanofi Pasteur Inc
Publication of DE602004017504D1 publication Critical patent/DE602004017504D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE200460017504 2003-11-17 2004-11-15 Impfstoffzusammensetzung im gemisch mit einem alkylphosphatidylcholin Active DE602004017504D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0313406A FR2862306B1 (fr) 2003-11-17 2003-11-17 Composition vaccinale
PCT/FR2004/002911 WO2005049080A1 (fr) 2003-11-17 2004-11-15 Composition vaccinale adjuvantee par une alkylphosphatidylcholine

Publications (1)

Publication Number Publication Date
DE602004017504D1 true DE602004017504D1 (de) 2008-12-11

Family

ID=34508504

Family Applications (1)

Application Number Title Priority Date Filing Date
DE200460017504 Active DE602004017504D1 (de) 2003-11-17 2004-11-15 Impfstoffzusammensetzung im gemisch mit einem alkylphosphatidylcholin

Country Status (23)

Country Link
US (2) US7344720B2 (de)
EP (1) EP1696954B1 (de)
JP (1) JP4638880B2 (de)
KR (1) KR101136107B1 (de)
CN (1) CN1882358B (de)
AT (1) ATE412429T1 (de)
AU (1) AU2004290943B2 (de)
BR (1) BRPI0416670A (de)
CA (1) CA2545086C (de)
CY (1) CY1108498T1 (de)
DE (1) DE602004017504D1 (de)
DK (1) DK1696954T3 (de)
ES (1) ES2311875T3 (de)
FR (1) FR2862306B1 (de)
IL (1) IL175573A (de)
LT (1) LT5435B (de)
LV (1) LV13457B (de)
NO (1) NO20062779L (de)
PL (1) PL1696954T3 (de)
PT (1) PT1696954E (de)
SI (1) SI1696954T1 (de)
WO (1) WO2005049080A1 (de)
ZA (1) ZA200603522B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100752990B1 (ko) 2006-08-02 2007-08-30 주식회사 대웅 나노리포좀 및 천연 추출물을 포함하는 피부 질환의 예방또는 치료용 조성물
TWI444384B (zh) * 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
CA2716399C (en) 2008-03-05 2020-07-21 Pierre Chouvenc Process for stabilizing an adjuvant containing vaccine composition
WO2010130898A2 (fr) 2009-05-14 2010-11-18 Sanofi Pasteur Vaccin meningocoque a base de lipooligosaccharide (los) provenant de souches modifiees de neisseria meningitidis d'immunotype l6
WO2010130897A1 (fr) * 2009-05-14 2010-11-18 Sanofi Pasteur Procédé de détoxification du lipopolysaccharide (lps) ou du lipide a des bactéries à gram-négatif
WO2010130896A2 (fr) 2009-05-14 2010-11-18 Sanofi Pasteur Procédé pour adjuver le lipopolysaccharide (lps) des bactéries à gram-négatif
EP2578974A1 (de) 2011-10-05 2013-04-10 Sanofi Pasteur Sa Verfahrenslinie zur Herstellung von gefriergetrockneten Partikeln
JP5761143B2 (ja) * 2011-11-02 2015-08-12 株式会社リコー 撮像ユニット、撮像ユニットを搭載した車両
US20140147475A1 (en) * 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
BR112015023870A2 (pt) 2013-03-18 2017-07-18 Intervet Int Bv vacina, uso de bactérias atenuadas vivas, método para proteger um ruminante contra pneumonia, e, bactérias atenuadas vivas
EP3171954B1 (de) 2014-07-21 2018-06-27 Sanofi Pasteur SA Flüssigkeitszuführvorrichtung zur erzeugung von tröpfchen und deren verwendung zur herstellung eine impfstoffzusammensetzung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100064A (en) 1984-04-06 2000-08-08 Chiron Corporation Secreted viral proteins useful for vaccines and diagnostics
FR2773156B1 (fr) 1997-12-26 2000-03-31 Biovacs Inc Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
ATE320792T1 (de) 2000-09-28 2006-04-15 Chiron Corp Mikropartikel zur verabreichung von heterologen nukleinsäure
EP1333858B8 (de) * 2000-11-07 2006-06-14 Immunovaccine Technologies Inc. Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung
US7303881B2 (en) * 2004-04-30 2007-12-04 Pds Biotechnology Corporation Antigen delivery compositions and methods of use

Also Published As

Publication number Publication date
WO2005049080B1 (fr) 2005-09-01
US7344720B2 (en) 2008-03-18
CA2545086C (en) 2011-11-08
SI1696954T1 (sl) 2009-04-30
EP1696954B1 (de) 2008-10-29
NO20062779L (no) 2006-08-15
CN1882358A (zh) 2006-12-20
DK1696954T3 (da) 2009-02-23
KR101136107B1 (ko) 2012-04-17
JP4638880B2 (ja) 2011-02-23
LT2006036A (en) 2007-05-25
FR2862306A1 (fr) 2005-05-20
IL175573A0 (en) 2006-09-05
CY1108498T1 (el) 2014-04-09
AU2004290943B2 (en) 2009-08-27
LT5435B (lt) 2007-07-25
FR2862306B1 (fr) 2008-05-30
CN1882358B (zh) 2011-02-02
IL175573A (en) 2010-06-30
ES2311875T3 (es) 2009-02-16
WO2005049080A1 (fr) 2005-06-02
EP1696954A1 (de) 2006-09-06
ZA200603522B (en) 2007-07-25
ATE412429T1 (de) 2008-11-15
LV13457B (en) 2007-01-20
PL1696954T3 (pl) 2009-04-30
BRPI0416670A (pt) 2007-02-13
US20050208060A1 (en) 2005-09-22
AU2004290943A1 (en) 2005-06-02
KR20060127385A (ko) 2006-12-12
JP2007511585A (ja) 2007-05-10
US7767658B2 (en) 2010-08-03
US20080131446A1 (en) 2008-06-05
CA2545086A1 (en) 2005-06-02
PT1696954E (pt) 2008-11-25

Similar Documents

Publication Publication Date Title
NO20062779L (no) Vaksinesammensetning blandet med en alkylfosfatidylkolin
CY1107081T1 (el) Λιπαρα οξεα, ως παραγοντες επιβιωσης κι ενεργοποιησης ουδετεροφιλων
CY1115719T1 (el) Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων
CY1108823T1 (el) Παραγωγα 2-υδροξυ-3-ετεροαρυλινδολης ως αναστολεις της gsk3
CY1114681T1 (el) Παραγωγο εστερα του αμινοφωσφορικου οξεος και τροποποιητης του υποδοχεα της 1-φωσφορικης σφιγγοσινης που το περιεχει ως δραστικο συστατικο
AR003415A1 (es) Compuestos analogos de lactacistina, metodo para inhibir la proteolisis dependiente de proteasoma, metodo para identificar un proceso biologico mediado por proteolisis dependiente de proteasoma, uso de dichos compuestos para preparar un medicamento para tratar una condicion mediada por proteolisis dependiente de proteasoma.
BRPI0406883A (pt) Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
CY1108295T1 (el) Παραγωγα μονοσακχαριτη αβερμεκτινης τα οποια εχουν παρασιτοκτονες ιδιοτητες
ES2186961T3 (es) Derivados de acido benzazepinona-n-acetico sustituidos por acido fosfonico, asi como procedimiento para su preparacion y medicamentos que contienen estos compuestos.
DE60116483D1 (de) Gelartige pharmazeutische zusammensetzung zur subcutanen anwendung enthaltend bisphosphonsäuren oder deren salze
AR004004A1 (es) Benzoilguanidinas sustituida, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento quelas contiene.
RU2009145537A (ru) Терапевтические соединения
BR0312385A (pt) Preparação, processos para produzir a mesma e uma ração contendo diformiato e/ou aditivo de ração, uso de uma preparação, e, ração animal
PT1280812E (pt) Ciclipostinas, processo para a sua preparacao e sua utilizacao
BR0213633A (pt) Método e composto para tratar de uma doença associada com recrutamento e/ou ativação aberrante de leucócitos
EA200000374A2 (ru) Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции
CY1110402T1 (el) Φαρμακευτικα και καλλυντικα σκευασματα για την περιποιηση των ονυχων
AR031712A1 (es) Metodo y composicion
KR890005119A (ko) 마크롤리드 화합물
ES2192608T3 (es) Uso de derivados de alilamina tales como terbinafina, en la fabricacion de un medicamento para el tratamiento de la infeccion por helicobacter pylori de enfermedades asociadas.
EA200100344A2 (ru) Новые циклобутаиндолкарбоксамидные производные, способ их получения и содержащие их фармацевтические композиции
AR045994A1 (es) Farmaco activo para el dolor neuropatico
AR016261A1 (es) Compuestos de eter de morfolino, proceso para su preparacion, uso para la preparacion de medicamentos, composicion farmaceutica
AR126702A1 (es) Compuestos fosfolípidos y métodos de preparación y uso de los mismos
ATE272047T1 (de) Perfluorierte ester von alkanoyl l-carnitin zur herstellung von kationischen lipiden zur intrazellulären verabreichung pharmakologisch aktiver verbindungen

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC

8364 No opposition during term of opposition